Physician profile
Patrick St Pierre
NPI 1548225931
$1,718,203.75
in general payments reported to CMS, 2019-2025
13 companies · $287K in 2025
The $287K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191K · 2020: $175K · 2021: $225K · 2022: $249K · 2023: $290K · 2024: $301K · 2025: $287K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $772K · Consulting Fee: $86K · Travel and Lodging: $15K · Food and Beverage: $4,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $772,033.18 |
| Consulting Fee | $86,365.00 |
| Travel and Lodging | $15,459.42 |
| Food and Beverage | $4,072.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $1,435,490.78 | 2019-2025 | Djo Surgical |
| Stryker Corporation | $207,811.95 | 2019-2025 | Mako, Tornier Perform Reversed Glenoid, Aequalis |
| Zimmer Biomet Holdings, INC. | $56,036.55 | 2019-2025 | Biowick X |
| Linvatec Corporation | $13,425.26 | 2022-2024 | Biobrace, Biobrace 23mm |
| Empire Medical, INC | $2,593.80 | 2022 | |
| Arthrex, INC. | $1,322.33 | 2022-2023 | Shoulder Implants Speedbridge Composite Anchors |
| Biorez, INC. | $914.04 | 2022 | |
| Aesculap Biologics, LLC | $181.96 | 2019-2021 | |
| Djo, LLC | $159.29 | 2019 | |
| Breg, INC | $114.21 | 2021 | |
| Pacira Therapeutics, INC. | $86.21 | 2019 | |
| Bioventus LLC | $67.37 | 2022-2023 | Durolane |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick St Pierre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.